Unrated UCB to market bond after two year absence
UCB, the unrated Belgian pharmaceuticals company, is sounding out demand for a senior unsecured euro bond for general financing purposes among European investors.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts